These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5402252)

  • 1. [Clinical studies with a new anticoronaritis preparation].
    Amadini S; Bagnoli L
    Minerva Cardioangiol; 1969 Aug; 17(8):532-48. PubMed ID: 5402252
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic possibilities in coronary disease].
    Zoli I; Baroncini S; Cornia GL; Donato S; Minore G; Pigini G; Pretolani E
    Minerva Med; 1973 Nov; 64(84):4445-57. PubMed ID: 4272415
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinico-theoretical considerations on the association of trifluoperazine and coronary vasoactive drugs in the treatment of anxiety states in aged cardiopathic patients].
    De Maio D
    Clin Ter; 1969 Dec; 51(6):571-6. PubMed ID: 5371380
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experiences with a combined preparation (butydrine and pentaerythritol tetranitrate) in coronary insufficiency].
    Chiti E
    Clin Ter; 1970 May; 53(4):315-21. PubMed ID: 4394192
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of Peritrate in acute coronary insufficiency].
    Tricot R; Valère P; Castillo A
    Therapeutique; 1971 Nov; 47(9):777-8. PubMed ID: 4947933
    [No Abstract]   [Full Text] [Related]  

  • 6. [Atherosclerosis progression and standard in coronary disease. Nitrate with special talents: PETN (pentaerythritol tetranitrate) is vasoprotective].
    MMW Fortschr Med; 2002 Nov; 144(45):51. PubMed ID: 12534064
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical results of the use of a new drug association in heart diseases].
    Chierici F; Artuso P; Suriani L
    Clin Ter; 1970 Feb; 52(3):219-57. PubMed ID: 5419244
    [No Abstract]   [Full Text] [Related]  

  • 8. [Electrolyte therapy of coronary insufficiency in the practice].
    Menzel M
    Landarzt; 1968 Jul; 44(20):993-5. PubMed ID: 5717732
    [No Abstract]   [Full Text] [Related]  

  • 9. [The combination preparation VisanoCor in patients with angina pectoris with special monitoring of urinary catecholamines].
    Hagel H
    Fortschr Med; 1981 Nov; 99(41):1714-7. PubMed ID: 7319440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Differential treatment of coronary heart disease].
    Weser C; Scheidler K
    Z Arztl Fortbild (Jena); 1974 Jul; 68(13):647-53. PubMed ID: 4216180
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical testing of a new combination product of a beta blocking agent and a nitroderivative].
    Melli A; Malagù I; Golinelli G; Soffritti A
    Minerva Med; 1970 Sep; 61(78):4271-8. PubMed ID: 4397054
    [No Abstract]   [Full Text] [Related]  

  • 12. [The hemodynamic profile of pentaerythrityl tetranitrate].
    Engelmann L; Gottschild D
    Z Gesamte Inn Med; 1981 Apr; 36(7):244-6. PubMed ID: 7281826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical study of a prolonged-action coronary vasodilator agent: pentaerythritol tetranitrate].
    Warembourg H; Théry C
    Lille Med; 1966; 11(6):742-5. PubMed ID: 5942195
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of coronary circulation disorders with Adenopurine].
    Mahr H
    Munch Med Wochenschr; 1966 Jan; 108(4):205-9. PubMed ID: 6013263
    [No Abstract]   [Full Text] [Related]  

  • 15. [The heparin tolerance test in the treatment of regional and diffuse atherosclerotic vascular diseases].
    Guglielmi G; Barlattani M
    Clin Ter; 1971 Aug; 58(3):229-42. PubMed ID: 5135002
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pentaerythritol tetranitrate effects on electrocardiographic changes induced by glucose loading].
    Ferlito S; Bonaventura S
    Policlinico Med; 1971; 78(6):252-62. PubMed ID: 5157399
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic effects of pentaerythritol tetranitrate in the immediate postmyocardial-infarction period.
    Mellen HS; Goldberg HS; Friedman HF
    N Engl J Med; 1967 Feb; 276(6):319-22. PubMed ID: 6016292
    [No Abstract]   [Full Text] [Related]  

  • 18. [Coronary therapy with Nitro-Sandolanid].
    Toker Y
    Munch Med Wochenschr; 1970 Apr; 112(17):809-12. PubMed ID: 5467991
    [No Abstract]   [Full Text] [Related]  

  • 19. [Value of combination therapy of pentalong (PETN) with obsidan (propranolol) in patients with coronary insufficiency].
    Gruber G; Hambsch K
    Z Arztl Fortbild (Jena); 1977 Feb; 71(4):167-71. PubMed ID: 868090
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical pharmacology].
    Nava Rivera A
    ADM; 1964; 21(6):457-9. PubMed ID: 5248027
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.